Chemycal has been acquired by 3E
Learn MoreChemycal has been acquired by 3E
Learn More
Discover how Chemycal PRO helps you boosting your regulatory monitoring:
Sept. 30 (UPI) -- The maker of generic versions of the anti-heartburn drug Zantac is recalling the medicine due to concerns of a possible link to cancer.
CONTINUE READING ON www.upi.com
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions
